News

Planned Parenthood of the Pacific Southwest has started offering an HIV prevention injection as part of its services, it was ...
While many big drug companies do amazing things for humanity, they’re also often vilified for profiteering from their work. This month, New York-listed Gilead Sciences has, not for the first time, ...
The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...
As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...
The world of HIV Prevention scored a major victory to end the year and it’s hard not to suspect that Santa Claus may have had a role in delivering this gift; well, maybe not Santa but the Food and ...
What kind of uptake can Gilead Sciences expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) ...
Yetzugo is a long-acting HIV-1 capsid inhibitor that reduces the risk of sexually acquired HIV in adults and adolescents.
Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...
Last week the US Food and Drug Administration approved Gilead Sciences Yeztugo (lenacapavir) for the prevention of HIV ...